Soft Tissue Sarcoma (STS) Recruiting Phase 2 Trials for Doxorubicin (DB00997)

Also known as: Sarcoma, Soft Tissue / Soft Tissue Sarcomas / Soft tissue sarcoma / Sarcoma,Soft Tissue / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Sarcoma

DBCOND0056871 (Soft Tissue Sarcoma (STS))Recruiting2 IdentifierTitlePurposeDrugs
NCT04012827Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue SarcomaTreatment
NCT03719430APX005M and Doxorubicin in Advanced SarcomaTreatment
NCT00790244A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk WallTreatment
NCT02584309Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaTreatment
NCT04356872The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue SarcomaTreatment